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66a Sunday, February 8, 2015aggregates slowly, than forAbeta42, which aggregates quickly. Furthermore, the
rate of reconfiguration for Abeta42 speeds up at higher pH, which slows aggre-
gation, and in the presence of the aggregation inhibitor curcumin. These results
are commensurate with a model of the first step of aggregation, described here,
that is a kinetic competition between reconfiguration and bimolecular diffusion.
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Alzheimer’s disease (AD), the most common form of dementia, is characterized
by extracellular plaques in the brain created when monomeric amyloid-b (Ab)
protein aggregates into fibrillar structures. Soluble Ab aggregates, including
oligomers that form along the reaction pathway, are believed to be themore toxic
species and can increase the production of reactive oxygen species (ROS). Poly-
phenols have been suggested as a complimentary AD therapeutic based on
epidemiological evidence that polyphenol-rich diets correlate with a reduced
incidence of AD. In particular, many flavonoids, a subclass of polyphenols,
have the ability to inhibit Ab aggregation. Alternatively, polyphenols can
counter Ab-induced cellular responses by neutralizing ROS through their anti-
oxidant properties. This study sought to identify polyphenols that can reduce
Ab-induced apoptosis by inhibiting Ab aggregation and/or reducing ROS.
Polyphenols investigated include quercetin (QUE), rhamnetin (RHA), isorham-
netin (IRHA), and tamarixetin (TAM). Using SDS-PAGE and Western blot to
evaluate oligomer size, only IRHA was unable to reduce Ab oligomers 250 –
100 kDa in size, while QUE reduced these oligomers by 88.35 2.4%. All com-
pounds reduced Ab oligomers <100 kDa in size, although IRHA was still the
weakest inhibitor. Antioxidant capabilities were quantified in vitro relative to
Trolox, a vitamin E analog. All compounds tested exhibited antioxidant capa-
bility similar to Trolox. To assess the effect of anti-aggregation and antioxidant
properties on Ab-induced apoptosis, human neuroblastoma cells were stained
using TUNEL, which identifies breaks in the DNA strand. Polyphenols with
anti-aggregation properties successfully reduced apoptosis, and it is hypothe-
sized that antioxidant activity will also have a protective effect.
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The aggregation and deposition of the polypeptide Amyloid-b (Ab) in the brain
is implicated in the pathology of Alzheimer disease (AD). It has been known
that soluble oligomeric forms of Ab are the primary neurotoxic agents in
AD, rather than insoluble fibrils. This has resulted in a plethora of research
investigating the cellular mechanism of Ab oligomer toxicity. However, how
these toxic oligomers proliferate throughout the AD brain remains elusive.
Emerging evidence implicates that a prion-like mechanism of propagation
may cause the widespread proliferation of toxic Ab oligomers in AD. We
have observed that a specific oligomeric form of Ab, called large fatty acid-
derived oligomers (LFAOs), undergo self-propagative replication in a
template-assisted manner, resulting in the formation of quantitatively more
LFAOs. The current research investigates the experimental parameters govern-
ing the efficiency of LFAO replication by self-propagation, and shows that
LFAOs specifically activate NF-kB in human neuroblastoma cells. Further-
more, structural characteristics of propagated LFAOs have been evaluated to
assess the fidelity of the LFAO self-propagative replication process. This study
is the first detailed investigation into the mechanisms governing self-
propagating Ab oligomers in vitro, revealing novel insight into the potential
proliferation mechanism of toxic Ab aggregates in AD.
333-Pos Board B113
Alzheimer’s Protective A2T Mutation Changes the Conformational Land-
scape of the Ab1-42 Monomer Differently than does the A2V Mutation
Payel Das.
IBM T J Watson research center, Yorktown heights, NY, USA.
The aggregation of amyloid-beta (Ab) peptides plays a crucial role in the eti-
ology of Alzheimer’s disease (AD). Recently, it has been reported that an
A2T mutation in Ab can protect from AD. Interestingly, a non-polar A2V mu-
tation has been also found to offer protection against AD in the heterozygous
state, while causing early-onset AD in homozygous carriers. Since the confor-
mational landscape of the Ab monomer is known to directly contribute to theearly-stage aggregation mechanism, it is important to characterize the effect
of the A2T and A2V mutations on the Ab1-42 monomer structure. Here, we
have performed extensive atomistic replica exchange molecular dynamics sim-
ulations of the solvated wild-type (WT), A2V, and A2T Ab1-42 monomers.
Our simulations reveal that, although all three variants remain as a collapsed
coil in solution, there exist significant structural differences among them at
shorter timescale. An enhanced double hairpin population in A2V is noticed
compared to WT, similar to those reported in the toxic WT Ab1-42 oligomers.
Hydrophobic clustering between the N-terminus and the central and C-terminal
hydrophobic patches promotes such double hairpin formation in A2V. In
contrast, the A2T mutation engages the N-terminus in unusual electrostatic in-
teractions with distant residues, such as K16 and E22, resulting in ‘‘unique’’
population comprising only the C-terminal hairpin. These findings imply that
a single A2X (X¼V/T) mutation in the primarily disordered N-terminus of
Ab1-42 monomer can dramatically alter the b-hairpin population and switch
the equilibrium toward alternative structures. The atomistically detailed,
comparative view of the structural landscapes of A2V and A2T variant mono-
mers obtained in this study can help understanding the mechanistic differences
in their early-stage aggregation.
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Alzheimer’s disease (AD) is a costly and devastating illness, which is charac-
terized by progressive neurological degeneration, manifesting in memory and
cognitive impairment until eventual death. Although the exact mechanism
for AD is unknown, it is hypothesized that disease etiology lies within the
aggregation of the protein amyloid-b (Ab), whose aggregates are toxic to
neuronal cells. Thus, inhibition of Ab aggregation is one therapeutic strategy.
Peptoids are peptide derivatives that resist proteolytic degradation through a
structural modification in the backbone, while maintaining side chain chemis-
try. This study examines the therapeutic potential of three peptoids designed to
mimic the hydrophobic core of Ab and incorporate a neutral, positive, or nega-
tive spacer between aromatic side chains. These peptoids are assessed for their
ability to abate Ab aggregation and reduce the aggregate-induced NF-kB acti-
vation in neuronal cells.
To examine the effect of peptoids on small, oligomeric aggregate formation,
Ab monomer was solubilized in DMSO and diluted into PBS to initiate olig-
omer formation. Oligomer size was assessed via SDS-PAGE and Western
blot; oligomer structure was evaluated using ANS. Finally, the effect of pep-
toids on Ab physiological activity was assessed using activation of NF-kB in
human neuroblastoma cells.
All three peptoids reduced the quantity and size of oligomers formed, with the
peptoid containing the positively charged spacer possessing the greatest inhib-
itory capabilities. In contrast, only peptoids containing a neutral or negatively
charged spacer also altered oligomer structure. NF-kB activation was signif-
icantly reduced for oligomers formed in the presence of all three peptoids.
In addition, when peptoid was added post-oligomerization, peptoids with a
neutral and negatively charged spacer both elicited a significant reduction
in NF-kB activation. In sum, peptoids are capable of inhibiting Ab oligomer-
ization and associated physiological activity, demonstrating potential as AD
therapeutics.
335-Pos Board B115
Effects of Carbon Nanoparticles on the Aggregation of Alzheimers Beta-
Amyloid Peptide
Yunxiang Sun, Luogang Xie, Dongdong Lin, Xinju Yang, Guanghong Wei.
Physics Department, Fudan University, Shanghai, China.
Amyloid deposits are implicated in the pathogenesis of many neurodegenera-
tive diseases such asAlzheimer’s disease (AD). The inhibition of b-sheet for-
mation has been considered as the primary therapeutic strategy for the AD.
In this presentation, I will present our recent results of the influences of
different carbon nanoparticles (CNPs) (including graphene oxides, pristine
single-walled carbon nanotubes–SWCNTs, hydroxylated SWCNTs, fullerenes
including C60 and C180) on the aggregation of Ab(16-22) and full-length Ab
peptides. Our replica exchange molecular dynamics (REMD) simulations
show that CNPs shift the conformations of Ab oligomers from ordered
b-sheet-rich structures toward disordered coil aggregates. Atomic force micro-
scopy (AFM) experiments further confirm the inhibitory effect of CNPs on Ab
